Author:
O’Dwyer Peter J.,Leyland-Jones Brian,Hoth Daniel F.
Reference154 articles.
1. Weber G: Biochemical strategy of cancer cells and the design of chemotherapy: GHA Clowes Memorial Lectures. Cancer Res 43:3466–3492, 1983.
2. O’Dwyer PJ, Marsoni S, Alonso MT, and Wittes RE: 2’-deoxycoformycin: Summary and future directions. Cancer Treat Symp 2:1–5, 1984.
3. Van der Weyden MB and Kelley WN: Human adenosine deaminase: Distribution and properties. J Biol Chem 251:5448–5456, 1976.
4. Smyth JF, Paine RM, Jackman AL, Harrap KR, Chassin MM, Adamson RH, and Johns DG: The clinical pharmacology of the adenosine deaminase inhibitor 2’-deoxycoformycin. Cancer Chemother Pharmacol 5:93–101, 1980.
5. Ganeshaguru K, Lee N, Llewellin P, Prentice HG, Hoffbrand AV, Catovsky D, Habeshaw JA, Robinson J, and Greaves MF: Adenosine deminase concentrations in leukemia and lymphoma: Relation to cell phenotypes. Leuk Res 5:215–222, 1981.